ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07-10 07:13
      ARKG Investment Tracker position change: Increased position in Eli Lilly by 6,403 shares, the number of shares held increased 16.04% compared to the previous period and now represents 3.38% of the total position.
      3Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-10 07:13
      ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 5,911 shares, the number of shares held increased 0.12% compared to the previous period and now represents 2.15% of the total position.
      45Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-10 07:13
      ARKG Investment Tracker position change: Increased position in COMPASS Pathways plc by 195,079 shares, the number of shares held increased 6.01% compared to the previous period and now represents 2.64% of the total position.
      28Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-10 07:13
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 45,432 shares, the number of shares held increased 4.44% compared to the previous period and now represents 1.02% of the total position.
      31Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-10 07:13
      ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 348 shares, the number of shares held increased 0.12% compared to the previous period and now represents 1.44% of the total position.
      56Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-10 07:13
      ARKG Investment Tracker position change: Decreased position in Personalis by 21,694 shares, the number of shares held decreased 0.28% compared to the previous period and now represents 6.47% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-10 07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 2,531 shares, the number of shares held increased 0.12% compared to the previous period and now represents 2% of the total position.
      25Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-10 07:13
      ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 22,335 shares, the number of shares held increased 0.17% compared to the previous period and now represents 3.07% of the total position.
      148Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-10 07:13
      ARKG Investment Tracker position change: Decreased position in BioNTech SE by 44,177 shares, the number of shares held decreased 35.53% compared to the previous period and now represents 0.45% of the total position.
      32Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07-10 07:13
      ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 69,860 shares, the number of shares held decreased 3.5% compared to the previous period and now represents 2.37% of the total position.
      329Comment
      Report
     
     
     
     

    Most Discussed